/Investor DB

Deerfield Management Company — 2021 Investments

9 investments dated 2021 · listed companies and verified rows first · show all

NXT Biomedicalnxtbiomedical.comMay 2021✓ verified

NXT Biomedical is a medical device incubator that develops and spins out startups building clinical medical technologies aimed at addressing unmet needs and reducing healthcare costs.

BiotechHealthtechMedical DevicesIrvine, US

Stanton Rowe(CEO)inDon Bobo(Director)

BoardKadhiresan V Kadir(Director)Steven Hochberg(Director)Andrew Cleeland(Director)

Board seatAndrew ElBardissi· per SEC Form D

Adaptive Phage Therapeuticsaphage.comin𝕏Series B · May 2021 · $41M

Aphage develops AI and sensor technologies to identify, track, and classify physical threats across borders, infrastructure, and transportation networks for government and security organizations.

AI & Machine LearningBiotechDefense TechGovTechGaithersburg, IL

Gregory L. Merril(Executive Officer, Director, Promoter)Carl R. Merril(Executive Officer, Director)in

BoardJonathan Leff(Director)inEvan Loh(Director)Jana Jensen(Director)Raymond L. Martz(Director)

Co-investorsHackensack Meridian Health Bear's DenMaryland TEDCOTEDCOAMR Action FundSofinnova Ventures

Encodiaencodia.comSeries C · Jan 2021 · $75MDefunct

San Diego protein-sequencing company behind the ProteoCode platform; ceased operations in late 2025.

Co-investorsARCH Venture PartnersDecheng CapitalAlexandriaGV (Google Ventures)Nan Fung Life SciencesNorthpond Ventures

Jaguar Gene Therapyjaguargenetherapy.cominSeries A · Apr 2021 · $139M

Jaguar Gene Therapy develops gene therapy treatments for severe genetic diseases, focusing on AAV-based platform therapies designed to deliver one-time, long-lasting treatments.

BiotechHealthtechMedical DevicesLake Forest, US

Joseph NolaninJoe Nolan, MBA(Chief Executive Officer)

Co-investorsAIFARCH Venture PartnersJDRF T1D FundGoldman SachsSamsung Ventures

Larkgetlark.aiin𝕏Oct 2021

Lark provides AI-powered testing infrastructure for engineering teams that can test UIs, APIs, SDKs, and async workflows through natural language tests.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US

Vijit Dhingra(Founder)inJack Brown(Founder)in

Co-investorsY CombinatorSteelSky VenturesAlpha Intelligence CapitalApplied AngelsArbor VenturesBridge Bank+4 more

Larktrylark.aiinOct 2021 · $100M

Lark develops AI agents that automate manual workflows for wholesale distributors, integrating with their existing ERP systems and learning from each distributor's historical data and team decisions.

Advanced ManufacturingAI & Machine LearningSan Francisco, US

Jason Wang(CEO)inMichael Wang(Co-Founder)in

Co-investorsY CombinatorFranklin TempletonKing River Capital

Nuvalentnuvalent.comin𝕏Series A · Jan 2021 · $50M

Nuvalent is a biopharmaceutical company focused on structure-based drug discovery and the development of precision oncology therapies.

BiotechHealthtechMedical DevicesCambridge, US

Matthew Shair(Director)inHenry Pelish, PhD(Chief Scientific Officer)R. Porter James(Executive Officer, Director)inJames Porter, PhD(Chief Executive Officer)Alex Balcom(Chief Financial Officer)inChristopher Turner, MD(Chief Medical Officer)

Co-investorsAvoro Capital AdvisorsBain Capital Life SciencesViking GlobalWellington Management

Ribon Therapeuticsribontx.cominSeries C · Jun 2021 · $65M

BiotechLexington, US

Victoria M. Richon(Executive Officer, Director)in

BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)

Co-investorsAvego BioScience CapitalOUP (Osage University Partners)Peregrine VenturesAbbVieJJDCNovartis Venture Fund+3 more

Vantavanta.comin𝕏Series A · May 2021 · $50M

Vanta provides a security and compliance platform that helps companies improve their security posture and demonstrate compliance to auditors.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSSan Francisco, US

Christina Cacioppo(CEO & Founder)inBrittany Rose(Executive Officer)Erik Goldman(Founder)Rob Picard(Security Lead)inMatt Long(Senior Software Engineer)inAlex Marquez-Shaw(Recruiter)

Co-investorsAcrew CapitalAtlassian VenturesBeyond CapitalBonfire VenturesCraft VenturesFPV+25 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.